Global Grass Pollen Allergy Drug Market

Grass Pollen Allergy Drug Comprehensive Study by Type (BM-32, Pollinex Quattro Grass, Others), Application (Home Use, Hospital, Research Center) Players and Region - Global Market Outlook to 2027

Grass Pollen Allergy Drug Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Grass Pollen Allergy Drug Market Overview:
Pollen allergy is an allergic condition affecting the mucous membranes of the nose and the eyes etc., usually characterized by nasal discharge, nasal congestion, and itchy and watery eyes, itchy nose, inner ears and roof of the mouth, that are caused by a hypersensitivity to airborne pollen, such as the pollen of trees, grasses, and weeds. Grass pollen allergy drugs can help ease symptoms of pollen allergy. Based on the drug type, the market has been segmented into BM-32, Pollinex Quattro Grass, and Others.

Growth Drivers
  • Exponential Rise in Number of Patient Suffering From Pollen Based Allergies and More Precisely Hay Fever
  • Weather Variables, Mainly Air Temperature, Sunlight, and Rainfall Together With Carbon Dioxide (CO2)
  • The Growing Number of Pollen Allergies among the Children’s

Roadblocks
  • Lack of Permanent Cure to Grass Pollen Allergy Disease and Home Based Diagnosis

Opportunities
  • The Increasing Grass Pollen Allergy Incidences among the North America & Oceana Regions


Competitive Landscape:

Some of the key players profiled in the report are Allergy Therapeutics plc. (United Kingdom), Allergopharma Joachim Ganzer KG (Germany), Circassia Pharmaceuticals Plc (United Kingdom), Laboratorios LETI S.L. (Spain), Anergis SA (Switzerland), Biomay AG (Austria), ALK-Abello A/S (Denmark), HAL Allergy BV (Netherlands) and Roxall Medizin GmbH (Germany). Analyst at AMA Research see United Kingdom, German Players to retain maximum share of Global Grass Pollen Allergy Drug market by 2027.

Latest Market Insights:
On 25 April 2019, Allergy Therapeutics (United Kingdom) got the regulatory green light for phase III grass pollen trial. The company has confirmed phase III trials of its short-course inoculation for grass pollen-induced hay fever will get underway in the second half of 2020.

On 22 Aug 2018, ALK has announced that the European regulatory filing for its investigational tree pollen sublingual allergy immunotherapy (SLIT) tablet has been accepted for review by the relevant health authorities via the decentralized procedure, with Germany as the reference member state.

What Can be Explored with the Grass Pollen Allergy Drug Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Grass Pollen Allergy Drug Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Grass Pollen Allergy Drug
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Grass Pollen Allergy Drug market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Grass Pollen Allergy Drug market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Grass Pollen Allergy Drug Manufacturers, Grass Pollen Allergy Drug Raw Material Suppliers, Grass Pollen Allergy Drug Traders/Distributors, Grass Pollen Allergy Importer/Exporter, Research Institutes, Regulatory & Government Bodies, End Users and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • BM-32
  • Pollinex Quattro Grass
  • Others
By Application
  • Home Use
  • Hospital
  • Research Center
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Exponential Rise in Number of Patient Suffering From Pollen Based Allergies and More Precisely Hay Fever
      • 3.2.2. Weather Variables, Mainly Air Temperature, Sunlight, and Rainfall Together With Carbon Dioxide (CO2)
      • 3.2.3. The Growing Number of Pollen Allergies among the Children’s
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Grass Pollen Allergy Drug, by Type, Application and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Grass Pollen Allergy Drug (Value)
      • 5.2.1. Global Grass Pollen Allergy Drug by: Type (Value)
        • 5.2.1.1. BM-32
        • 5.2.1.2. Pollinex Quattro Grass
        • 5.2.1.3. Others
      • 5.2.2. Global Grass Pollen Allergy Drug by: Application (Value)
        • 5.2.2.1. Home Use
        • 5.2.2.2. Hospital
        • 5.2.2.3. Research Center
      • 5.2.3. Global Grass Pollen Allergy Drug Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Grass Pollen Allergy Drug (Volume)
      • 5.3.1. Global Grass Pollen Allergy Drug by: Type (Volume)
        • 5.3.1.1. BM-32
        • 5.3.1.2. Pollinex Quattro Grass
        • 5.3.1.3. Others
      • 5.3.2. Global Grass Pollen Allergy Drug by: Application (Volume)
        • 5.3.2.1. Home Use
        • 5.3.2.2. Hospital
        • 5.3.2.3. Research Center
      • 5.3.3. Global Grass Pollen Allergy Drug Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Grass Pollen Allergy Drug (Price)
      • 5.4.1. Global Grass Pollen Allergy Drug by: Type (Price)
  • 6. Grass Pollen Allergy Drug: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Allergy Therapeutics plc. (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Allergopharma Joachim Ganzer KG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Circassia Pharmaceuticals Plc (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Laboratorios LETI S.L. (Spain)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Anergis SA (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Biomay AG (Austria)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ALK-Abello A/S (Denmark)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. HAL Allergy BV (Netherlands)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Roxall Medizin GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Grass Pollen Allergy Drug Sale, by Type, Application and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Grass Pollen Allergy Drug (Value)
      • 7.2.1. Global Grass Pollen Allergy Drug by: Type (Value)
        • 7.2.1.1. BM-32
        • 7.2.1.2. Pollinex Quattro Grass
        • 7.2.1.3. Others
      • 7.2.2. Global Grass Pollen Allergy Drug by: Application (Value)
        • 7.2.2.1. Home Use
        • 7.2.2.2. Hospital
        • 7.2.2.3. Research Center
      • 7.2.3. Global Grass Pollen Allergy Drug Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Grass Pollen Allergy Drug (Volume)
      • 7.3.1. Global Grass Pollen Allergy Drug by: Type (Volume)
        • 7.3.1.1. BM-32
        • 7.3.1.2. Pollinex Quattro Grass
        • 7.3.1.3. Others
      • 7.3.2. Global Grass Pollen Allergy Drug by: Application (Volume)
        • 7.3.2.1. Home Use
        • 7.3.2.2. Hospital
        • 7.3.2.3. Research Center
      • 7.3.3. Global Grass Pollen Allergy Drug Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Grass Pollen Allergy Drug (Price)
      • 7.4.1. Global Grass Pollen Allergy Drug by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Grass Pollen Allergy Drug: by Type(USD Million)
  • Table 2. Grass Pollen Allergy Drug BM-32 , by Region USD Million (2016-2021)
  • Table 3. Grass Pollen Allergy Drug Pollinex Quattro Grass , by Region USD Million (2016-2021)
  • Table 4. Grass Pollen Allergy Drug Others , by Region USD Million (2016-2021)
  • Table 5. Grass Pollen Allergy Drug: by Application(USD Million)
  • Table 6. Grass Pollen Allergy Drug Home Use , by Region USD Million (2016-2021)
  • Table 7. Grass Pollen Allergy Drug Hospital , by Region USD Million (2016-2021)
  • Table 8. Grass Pollen Allergy Drug Research Center , by Region USD Million (2016-2021)
  • Table 9. South America Grass Pollen Allergy Drug, by Country USD Million (2016-2021)
  • Table 10. South America Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 11. South America Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 12. Brazil Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 13. Brazil Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 14. Argentina Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 15. Argentina Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 16. Rest of South America Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 17. Rest of South America Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 18. Asia Pacific Grass Pollen Allergy Drug, by Country USD Million (2016-2021)
  • Table 19. Asia Pacific Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 20. Asia Pacific Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 21. China Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 22. China Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 23. Japan Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 24. Japan Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 25. India Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 26. India Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 27. South Korea Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 28. South Korea Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 29. Taiwan Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 30. Taiwan Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 31. Australia Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 32. Australia Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 33. Rest of Asia-Pacific Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 34. Rest of Asia-Pacific Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 35. Europe Grass Pollen Allergy Drug, by Country USD Million (2016-2021)
  • Table 36. Europe Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 37. Europe Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 38. Germany Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 39. Germany Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 40. France Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 41. France Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 42. Italy Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 43. Italy Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 44. United Kingdom Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 45. United Kingdom Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 46. Netherlands Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 47. Netherlands Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 48. Rest of Europe Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 49. Rest of Europe Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 50. MEA Grass Pollen Allergy Drug, by Country USD Million (2016-2021)
  • Table 51. MEA Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 52. MEA Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 53. Middle East Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 54. Middle East Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 55. Africa Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 56. Africa Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 57. North America Grass Pollen Allergy Drug, by Country USD Million (2016-2021)
  • Table 58. North America Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 59. North America Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 60. United States Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 61. United States Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 62. Canada Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 63. Canada Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 64. Mexico Grass Pollen Allergy Drug, by Type USD Million (2016-2021)
  • Table 65. Mexico Grass Pollen Allergy Drug, by Application USD Million (2016-2021)
  • Table 66. Grass Pollen Allergy Drug Sales: by Type(Kilo Tons)
  • Table 67. Grass Pollen Allergy Drug Sales BM-32 , by Region Kilo Tons (2016-2021)
  • Table 68. Grass Pollen Allergy Drug Sales Pollinex Quattro Grass , by Region Kilo Tons (2016-2021)
  • Table 69. Grass Pollen Allergy Drug Sales Others , by Region Kilo Tons (2016-2021)
  • Table 70. Grass Pollen Allergy Drug Sales: by Application(Kilo Tons)
  • Table 71. Grass Pollen Allergy Drug Sales Home Use , by Region Kilo Tons (2016-2021)
  • Table 72. Grass Pollen Allergy Drug Sales Hospital , by Region Kilo Tons (2016-2021)
  • Table 73. Grass Pollen Allergy Drug Sales Research Center , by Region Kilo Tons (2016-2021)
  • Table 74. South America Grass Pollen Allergy Drug Sales, by Country Kilo Tons (2016-2021)
  • Table 75. South America Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 76. South America Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 77. Brazil Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 78. Brazil Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 79. Argentina Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 80. Argentina Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 81. Rest of South America Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 82. Rest of South America Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 83. Asia Pacific Grass Pollen Allergy Drug Sales, by Country Kilo Tons (2016-2021)
  • Table 84. Asia Pacific Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 85. Asia Pacific Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 86. China Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 87. China Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 88. Japan Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 89. Japan Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 90. India Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 91. India Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 92. South Korea Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 93. South Korea Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 94. Taiwan Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 95. Taiwan Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 96. Australia Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 97. Australia Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 98. Rest of Asia-Pacific Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 99. Rest of Asia-Pacific Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 100. Europe Grass Pollen Allergy Drug Sales, by Country Kilo Tons (2016-2021)
  • Table 101. Europe Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 102. Europe Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 103. Germany Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 104. Germany Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 105. France Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 106. France Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 107. Italy Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 108. Italy Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 109. United Kingdom Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 110. United Kingdom Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 111. Netherlands Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 112. Netherlands Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 113. Rest of Europe Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 114. Rest of Europe Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 115. MEA Grass Pollen Allergy Drug Sales, by Country Kilo Tons (2016-2021)
  • Table 116. MEA Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 117. MEA Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 118. Middle East Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 119. Middle East Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 120. Africa Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 121. Africa Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 122. North America Grass Pollen Allergy Drug Sales, by Country Kilo Tons (2016-2021)
  • Table 123. North America Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 124. North America Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 125. United States Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 126. United States Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 127. Canada Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 128. Canada Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 129. Mexico Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2016-2021)
  • Table 130. Mexico Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2016-2021)
  • Table 131. Grass Pollen Allergy Drug: by Type(USD/Units)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Grass Pollen Allergy Drug: by Type(USD Million)
  • Table 142. Grass Pollen Allergy Drug BM-32 , by Region USD Million (2022-2027)
  • Table 143. Grass Pollen Allergy Drug Pollinex Quattro Grass , by Region USD Million (2022-2027)
  • Table 144. Grass Pollen Allergy Drug Others , by Region USD Million (2022-2027)
  • Table 145. Grass Pollen Allergy Drug: by Application(USD Million)
  • Table 146. Grass Pollen Allergy Drug Home Use , by Region USD Million (2022-2027)
  • Table 147. Grass Pollen Allergy Drug Hospital , by Region USD Million (2022-2027)
  • Table 148. Grass Pollen Allergy Drug Research Center , by Region USD Million (2022-2027)
  • Table 149. South America Grass Pollen Allergy Drug, by Country USD Million (2022-2027)
  • Table 150. South America Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 151. South America Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 152. Brazil Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 153. Brazil Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 154. Argentina Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 155. Argentina Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 156. Rest of South America Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 157. Rest of South America Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 158. Asia Pacific Grass Pollen Allergy Drug, by Country USD Million (2022-2027)
  • Table 159. Asia Pacific Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 160. Asia Pacific Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 161. China Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 162. China Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 163. Japan Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 164. Japan Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 165. India Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 166. India Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 167. South Korea Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 168. South Korea Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 169. Taiwan Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 170. Taiwan Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 171. Australia Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 172. Australia Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 173. Rest of Asia-Pacific Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 174. Rest of Asia-Pacific Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 175. Europe Grass Pollen Allergy Drug, by Country USD Million (2022-2027)
  • Table 176. Europe Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 177. Europe Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 178. Germany Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 179. Germany Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 180. France Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 181. France Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 182. Italy Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 183. Italy Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 184. United Kingdom Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 185. United Kingdom Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 186. Netherlands Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 187. Netherlands Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 188. Rest of Europe Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 189. Rest of Europe Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 190. MEA Grass Pollen Allergy Drug, by Country USD Million (2022-2027)
  • Table 191. MEA Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 192. MEA Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 193. Middle East Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 194. Middle East Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 195. Africa Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 196. Africa Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 197. North America Grass Pollen Allergy Drug, by Country USD Million (2022-2027)
  • Table 198. North America Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 199. North America Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 200. United States Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 201. United States Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 202. Canada Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 203. Canada Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 204. Mexico Grass Pollen Allergy Drug, by Type USD Million (2022-2027)
  • Table 205. Mexico Grass Pollen Allergy Drug, by Application USD Million (2022-2027)
  • Table 206. Grass Pollen Allergy Drug Sales: by Type(Kilo Tons)
  • Table 207. Grass Pollen Allergy Drug Sales BM-32 , by Region Kilo Tons (2022-2027)
  • Table 208. Grass Pollen Allergy Drug Sales Pollinex Quattro Grass , by Region Kilo Tons (2022-2027)
  • Table 209. Grass Pollen Allergy Drug Sales Others , by Region Kilo Tons (2022-2027)
  • Table 210. Grass Pollen Allergy Drug Sales: by Application(Kilo Tons)
  • Table 211. Grass Pollen Allergy Drug Sales Home Use , by Region Kilo Tons (2022-2027)
  • Table 212. Grass Pollen Allergy Drug Sales Hospital , by Region Kilo Tons (2022-2027)
  • Table 213. Grass Pollen Allergy Drug Sales Research Center , by Region Kilo Tons (2022-2027)
  • Table 214. South America Grass Pollen Allergy Drug Sales, by Country Kilo Tons (2022-2027)
  • Table 215. South America Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 216. South America Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 217. Brazil Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 218. Brazil Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 219. Argentina Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 220. Argentina Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 221. Rest of South America Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 222. Rest of South America Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 223. Asia Pacific Grass Pollen Allergy Drug Sales, by Country Kilo Tons (2022-2027)
  • Table 224. Asia Pacific Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 225. Asia Pacific Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 226. China Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 227. China Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 228. Japan Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 229. Japan Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 230. India Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 231. India Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 232. South Korea Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 233. South Korea Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 234. Taiwan Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 235. Taiwan Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 236. Australia Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 237. Australia Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 238. Rest of Asia-Pacific Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 239. Rest of Asia-Pacific Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 240. Europe Grass Pollen Allergy Drug Sales, by Country Kilo Tons (2022-2027)
  • Table 241. Europe Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 242. Europe Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 243. Germany Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 244. Germany Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 245. France Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 246. France Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 247. Italy Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 248. Italy Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 249. United Kingdom Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 250. United Kingdom Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 251. Netherlands Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 252. Netherlands Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 253. Rest of Europe Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 254. Rest of Europe Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 255. MEA Grass Pollen Allergy Drug Sales, by Country Kilo Tons (2022-2027)
  • Table 256. MEA Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 257. MEA Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 258. Middle East Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 259. Middle East Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 260. Africa Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 261. Africa Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 262. North America Grass Pollen Allergy Drug Sales, by Country Kilo Tons (2022-2027)
  • Table 263. North America Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 264. North America Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 265. United States Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 266. United States Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 267. Canada Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 268. Canada Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 269. Mexico Grass Pollen Allergy Drug Sales, by Type Kilo Tons (2022-2027)
  • Table 270. Mexico Grass Pollen Allergy Drug Sales, by Application Kilo Tons (2022-2027)
  • Table 271. Grass Pollen Allergy Drug: by Type(USD/Units)
  • Table 272. Research Programs/Design for This Report
  • Table 273. Key Data Information from Secondary Sources
  • Table 274. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Grass Pollen Allergy Drug: by Type USD Million (2016-2021)
  • Figure 5. Global Grass Pollen Allergy Drug: by Application USD Million (2016-2021)
  • Figure 6. South America Grass Pollen Allergy Drug Share (%), by Country
  • Figure 7. Asia Pacific Grass Pollen Allergy Drug Share (%), by Country
  • Figure 8. Europe Grass Pollen Allergy Drug Share (%), by Country
  • Figure 9. MEA Grass Pollen Allergy Drug Share (%), by Country
  • Figure 10. North America Grass Pollen Allergy Drug Share (%), by Country
  • Figure 11. Global Grass Pollen Allergy Drug: by Type Kilo Tons (2016-2021)
  • Figure 12. Global Grass Pollen Allergy Drug: by Application Kilo Tons (2016-2021)
  • Figure 13. South America Grass Pollen Allergy Drug Share (%), by Country
  • Figure 14. Asia Pacific Grass Pollen Allergy Drug Share (%), by Country
  • Figure 15. Europe Grass Pollen Allergy Drug Share (%), by Country
  • Figure 16. MEA Grass Pollen Allergy Drug Share (%), by Country
  • Figure 17. North America Grass Pollen Allergy Drug Share (%), by Country
  • Figure 18. Global Grass Pollen Allergy Drug: by Type USD/Units (2016-2021)
  • Figure 19. Global Grass Pollen Allergy Drug share by Players 2021 (%)
  • Figure 20. Global Grass Pollen Allergy Drug share by Players (Top 3) 2021(%)
  • Figure 21. Global Grass Pollen Allergy Drug share by Players (Top 5) 2021(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. Allergy Therapeutics plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. Allergy Therapeutics plc. (United Kingdom) Revenue: by Geography 2021
  • Figure 25. Allergopharma Joachim Ganzer KG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Allergopharma Joachim Ganzer KG (Germany) Revenue: by Geography 2021
  • Figure 27. Circassia Pharmaceuticals Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Circassia Pharmaceuticals Plc (United Kingdom) Revenue: by Geography 2021
  • Figure 29. Laboratorios LETI S.L. (Spain) Revenue, Net Income and Gross profit
  • Figure 30. Laboratorios LETI S.L. (Spain) Revenue: by Geography 2021
  • Figure 31. Anergis SA (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Anergis SA (Switzerland) Revenue: by Geography 2021
  • Figure 33. Biomay AG (Austria) Revenue, Net Income and Gross profit
  • Figure 34. Biomay AG (Austria) Revenue: by Geography 2021
  • Figure 35. ALK-Abello A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 36. ALK-Abello A/S (Denmark) Revenue: by Geography 2021
  • Figure 37. HAL Allergy BV (Netherlands) Revenue, Net Income and Gross profit
  • Figure 38. HAL Allergy BV (Netherlands) Revenue: by Geography 2021
  • Figure 39. Roxall Medizin GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 40. Roxall Medizin GmbH (Germany) Revenue: by Geography 2021
  • Figure 41. Global Grass Pollen Allergy Drug: by Type USD Million (2022-2027)
  • Figure 42. Global Grass Pollen Allergy Drug: by Application USD Million (2022-2027)
  • Figure 43. South America Grass Pollen Allergy Drug Share (%), by Country
  • Figure 44. Asia Pacific Grass Pollen Allergy Drug Share (%), by Country
  • Figure 45. Europe Grass Pollen Allergy Drug Share (%), by Country
  • Figure 46. MEA Grass Pollen Allergy Drug Share (%), by Country
  • Figure 47. North America Grass Pollen Allergy Drug Share (%), by Country
  • Figure 48. Global Grass Pollen Allergy Drug: by Type Kilo Tons (2022-2027)
  • Figure 49. Global Grass Pollen Allergy Drug: by Application Kilo Tons (2022-2027)
  • Figure 50. South America Grass Pollen Allergy Drug Share (%), by Country
  • Figure 51. Asia Pacific Grass Pollen Allergy Drug Share (%), by Country
  • Figure 52. Europe Grass Pollen Allergy Drug Share (%), by Country
  • Figure 53. MEA Grass Pollen Allergy Drug Share (%), by Country
  • Figure 54. North America Grass Pollen Allergy Drug Share (%), by Country
  • Figure 55. Global Grass Pollen Allergy Drug: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Allergy Therapeutics plc. (United Kingdom)
  • Allergopharma Joachim Ganzer KG (Germany)
  • Circassia Pharmaceuticals Plc (United Kingdom)
  • Laboratorios LETI S.L. (Spain)
  • Anergis SA (Switzerland)
  • Biomay AG (Austria)
  • ALK-Abello A/S (Denmark)
  • HAL Allergy BV (Netherlands)
  • Roxall Medizin GmbH (Germany)
Select User Access Type

Key Highlights of Report


Feb 2022 230 Pages 61 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Grass Pollen Allergy Drug Market Quantitative research analysis
Global Grass Pollen Allergy Drug Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Grass Pollen Allergy Drug market is expected to see a CAGR of % during projected year 2021 to 2027.
Top performing companies in the Global Grass Pollen Allergy Drug market are Allergy Therapeutics plc. (United Kingdom), Allergopharma Joachim Ganzer KG (Germany), Circassia Pharmaceuticals Plc (United Kingdom), Laboratorios LETI S.L. (Spain), Anergis SA (Switzerland), Biomay AG (Austria), ALK-Abello A/S (Denmark), HAL Allergy BV (Netherlands) and Roxall Medizin GmbH (Germany), to name a few.

Know More About Global Grass Pollen Allergy Drug Market Report?

Have a Query? Click Here

Other Related Reports

Amlodipine Besylater Comprehensive Study by Type (2.5mg, 5mg, 10mg), Application (High Blood Pressure, Heart Disease), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies...
$ 3650
Mouth Ulcers Drugs Comprehensive Study by Type (Corticosteroid , Anesthetic , Analgesic , Antihistamine , Antimicrobial), Application (Adults, Kids), Indication Type (Aphthous Stomatitis, Oral Lichen...
$ 3650
Sterile Medical Packaging Comprehensive Study by Type (Thermoform trays, Sterile bottles & containers, Vials & ampoules, Pre-fillable inhalers, Sterile closures, Pre-filled syringes, Blister & clamsh...
$ 3750
Specialty Pharmaceutical Comprehensive Study by Application (Hospitals, Specialty Pharmacies, Others (Mail Order)), Route of administration (Oral, Parenteral, Transdermal), Therapeutic area (Oncolo...
$ 3650
Anticoagulant Drug Comprehensive Study by Type (Coumarins & Indandiones, Factor Xa Inhibitors, Heparins, Thrombin Inhibitors), Application (Atrial Fibrillation, Deep Vein Thrombosis, Artificial Heart...
$ 3750
Neurological Disorder Drugs Comprehensive Study by Type (Antipsychotic, Antiepileptic, Anticholinergic, Analgesics, Hypnotic and Sedative, Antihypertensive, Anticoagulants, Others), Application (Hosp...
$ 3750